Related references
Note: Only part of the references are listed.Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation
Christopher J. Greene et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Molecular and Metabolic Basis of Clear Cell Carcinoma of the Kidney
Mohammed Akhtar et al.
ADVANCES IN ANATOMIC PATHOLOGY (2018)
Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways
Cheolwon Choi et al.
ONCOGENESIS (2018)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Treatment of renal cell carcinoma: Current status and future directions
Pedro C. Barata et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Renal Cancer in the Elderly
Tania Gonzalez Leon et al.
CURRENT UROLOGY REPORTS (2016)
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database
I. Wolff et al.
EJSO (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours
Peter A. Humphrey et al.
EUROPEAN UROLOGY (2016)
Moving targets: Emerging roles for MMPs in cancer progression and metastasis
Gemma Shay et al.
MATRIX BIOLOGY (2015)
2′-Hydroxyflavanone inhibits prostate tumor growth through inactivation of AKT/STAT3 signaling and induction of cell apoptosis
Kaijie Wu et al.
ONCOLOGY REPORTS (2014)
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
Jiri Polivka et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness
Kaijie Wu et al.
CELLULAR SIGNALLING (2013)
MUC15 Inhibits Dimerization of EGFR and PI3K-AKT Signaling and Is Associated With Aggressive Hepatocellular Carcinomas in Patients
Ruo-Yu Wang et al.
GASTROENTEROLOGY (2013)
PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes
Ipsita Pal et al.
ACTA PHARMACOLOGICA SINICA (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Mucins in human neoplasms: Clinical pathology, gene expression and diagnostic application
Suguru Yonezawa et al.
PATHOLOGY INTERNATIONAL (2011)
Expression of the Membrane Mucins MUC4 and MUC15, Potential Markers of Malignancy and Prognosis, in Papillary Thyroid Carcinoma
Kee-Hyun Nam et al.
THYROID (2011)
Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells
John Huang et al.
CARCINOGENESIS (2009)
Characterization of Human Mucin (MUC15) and Identification of Ovine and Caprine Orthologs
L. T. Pallesen et al.
JOURNAL OF DAIRY SCIENCE (2008)
Mucin 15 is expressed in human placenta and suppresses invasion of trophoblast-like cells in vitro
Ming-Kwang Shyu et al.
HUMAN REPRODUCTION (2007)
Mucin gene expression in human middle ear epithelium
Joseph Edward Kerschner
LARYNGOSCOPE (2007)
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: An International Multicenter Study
JJ Patard et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Mucins and mucin binding proteins in colorectal cancer
JC Byrd et al.
CANCER AND METASTASIS REVIEWS (2004)
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score
I Frank et al.
JOURNAL OF UROLOGY (2002)
Isolation and characterization of MUC15, a novel cell membrane-associated mucin
LT Pallesen et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Share Paper
